Dr. GPCR Podcast

About this episode

In this episode of the Dr. GPCR Podcast, I spoke to Dr. Aaron Sato from Twist Biopharma, a vertical within Twist Bioscience. Aaron is currently the Chief Scientific Officer and VP of Protein Engineering. He earned his Ph.D. at the Massachusetts Institute of Technology, where he studied MHC class II structure-function relationships. His path led him to work in an industry where he assumed various responsibilities and roles in the antibody space. Aaron has a proven track record as a biologics leader as he led teams to discover and develop novel first-in-class antibody therapeutics. Dr. Sato published over 30 peer-reviewed papers and contributed to 40 issued patents in the antibody space.

During our time together, Aaron and I discussed how using Twist Bioscience’s proprietary technology to manufacture DNA at a scale, the team saw an opportunity to tackle the challenge of identifying novel functional antibodies targeting GPCRs by incorporating these natural binding partners into Twist’s antibody library design.

We’d like to extend a special thanks to Twist Biopharma for sponsoring this episode of the Dr. GPCR podcast.

Dr. Aaron Sato on the web

• LinkedIn

• Twitter

• Google Scholar

• Twist Bioscience

• Twist Biopharma

• Dr. GPCR Ecosystem